Samumed
Toggle navigation
Home
About
Company
Technology
Team
Contact Us
Advisors
Patients
Pipeline
Osteoarthritis
Degenerative Disc Disease
Idiopathic Pulmonary Fibrosis
Psoriasis
Tendinopathy
Androgenetic Alopecia
Oncology
Alzheimer’s Disease
Full Pipeline
Publications
News
Careers
SAMUMED NEWS
VIEW ALL
Samumed Doses First Subject in Phase 3 STRIDES-X-ray Trial of Lorecivivint for the Treatment of Knee Osteoarthritis
Learn More
Samumed Launches Phase 3 Lorecivivint (SM04690) Clinical Program in Knee Osteoarthritis
Learn More
updates
×
Missed an issue? Catch up on our previous newsletters!
May 2019
February 2019
January 2019
Archive
ABOUT SAMUMED
Pipeline
Publications
Company
Team
Technology
×
The Wnt Pathway
Your browser does not support HTML5 video.